SELT expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.611800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.279200E-01
Normal-vs-Stage2
8.939000E-01
Normal-vs-Stage3
2.699200E-01
Normal-vs-Stage4
9.103400E-01
Stage1-vs-Stage2
2.130200E-01
Stage1-vs-Stage3
7.945800E-02
Stage1-vs-Stage4
6.725200E-01
Stage2-vs-Stage3
2.395800E-01
Stage2-vs-Stage4
7.147800E-01
Stage3-vs-Stage4
4.131800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.456200E-01
Normal-vs-AfricanAmerican
8.847400E-01
Normal-vs-Asian
6.307800E-01
Caucasian-vs-AfricanAmerican
7.209000E-01
Caucasian-vs-Asian
4.201400E-01
AfricanAmerican-vs-Asian
4.684800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.423800E-01
Normal-vs-Female
9.952000E-01
Male-vs-Female
7.519800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.748000E-01
Normal-vs-Age(41-60Yrs)
5.974000E-01
Normal-vs-Age(61-80Yrs)
7.668000E-01
Normal-vs-Age(81-100Yrs)
4.419000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.607200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.459400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.224000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.203100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.522200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.650400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.769400E-01
Normal-vs-Daily Drinker
4.466600E-01
Normal-vs-Weekly Drinker
2.656400E-01
Normal-vs-Occasional Drinker
4.554000E-01
Normal-vs-Social Drinker
9.212400E-01
Non Drinker-vs-Daily Drinker
8.525000E-01
Non Drinker-vs-Weekly Drinker
4.081200E-01
Non Drinker-vs-Occasional Drinker
8.343800E-03
Non Drinker-vs-Social Drinker
2.404200E-01
Daily Drinker-vs-Weekly Drinker
4.673600E-01
Daily Drinker-vs-Occasional Drinker
1.247920E-02
Daily Drinker-vs-Social Drinker
1.791160E-01
Weekly Drinker-vs-Occasional Drinker
7.777800E-03
Weekly Drinker-vs-Social Drinker
9.614300E-02
Occasional Drinker-vs-Social Drinker
2.212000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.861600E-02
Normal-vs-Grade 2
3.205000E-03
Normal-vs-Grade 3
1.364280E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.225600E-01
Grade 1-vs-Grade 3
4.954800E-01
Grade 1-vs-Grade 4
4.861600E-02
Grade 2-vs-Grade 3
5.748000E-01
Grade 2-vs-Grade 4
3.205000E-03
Grade 3-vs-Grade 4
1.364280E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.104600E-01
Normal-vs-NonDiabetic
9.797400E-01
Diabetic-vs-NonDiabetic
8.023600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.636600E-01
Normal-vs-NoPancreatitis
9.315000E-01
Pancreatitis-vs-NoPancreatitis
4.056200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.427000E-01
Normal-vs-N1
9.060400E-01
N0-vs-N1
5.065600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.647800E-01
Normal-vs-TP53-NonMutant
9.372800E-01
TP53-Mutant-vs-TP53-NonMutant
2.878000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
